Polypharmacy is associated with poor clinical outcomes following COVID-19 infection among patients with type 2 diabetes.
Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback